MindWalk Holdings (HYFT) Current Deferred Revenue (2020 - 2026)
MindWalk Holdings (HYFT) reported Current Deferred Revenue of $353079.2 for Q1 2026, down 49.52% year-over-year from $699495.9 in Q1 2025, and up 14.44% quarter-over-quarter from $308536.2 in Q4 2025.
MindWalk Holdings (HYFT) Current Deferred Revenue (2020 - 2026) Analysis & Trends
MindWalk Holdings (HYFT) has 7 years of Current Deferred Revenue data on file, last reported at $353079.2 in Q1 2026.
- Current Deferred Revenue for Q1 2026 came in at $353079.2, down 49.52% year-over-year; the trailing twelve-month figure through Jan 2026 was $353079.2 (down 49.52% YoY), and the FY2025 annual result was $782497.2, down 21.52% from the prior year.
- Current Deferred Revenue improved to $353079.2 in Q1 2026 per HYFT's latest filing, from $308536.2 in the prior quarter.
- Over five years, Current Deferred Revenue peaked at $1.1 million in Q3 2022 and troughed at -$177934.7 in Q1 2023.
- A 5-year average of $505182.8 and a median of $565489.2 in 2025 frame the typical range for Current Deferred Revenue.
- The sharpest annual moves came in 2024 and 2025: Current Deferred Revenue tumbled 137.1% in 2024, then soared 1412.39% in 2025.
- A 5-year view of Current Deferred Revenue shows it stood at $110675.6 in 2022, then soared by 319.8% to $464621.1 in 2023, then sank by 44.52% to $257765.6 in 2024, then gained by 19.7% to $308536.2 in 2025, then climbed by 14.44% to $353079.2 in 2026.
- Business Quant data shows HYFT's Current Deferred Revenue at $353079.2 in Q1 2026, $308536.2 in Q4 2025, and $565489.2 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - |
| 10 | MindWalk Holdings | 166.20 Mn | 156.06 Mn | 1.78 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2026 | 353,079.15 |
| Oct 31, 2025 | 308,536.21 |
| Jul 31, 2025 | 565,489.20 |
| Apr 30, 2025 | 765,974.27 |
| Jan 31, 2025 | 699,495.86 |
| Oct 31, 2024 | 257,765.62 |
| Jul 31, 2024 | -43,088.41 |
| Apr 30, 2024 | 997,127.42 |
| Jan 31, 2024 | 776,707.55 |
| Oct 31, 2023 | 464,621.15 |
| Jul 31, 2023 | 116,126.59 |
| Apr 30, 2023 | 722,051.05 |
| Jan 31, 2023 | -177,934.66 |
| Oct 31, 2022 | 110,675.63 |
| Jul 31, 2022 | 1.08 Mn |
| Apr 30, 2022 | 816,400.01 |
| Jan 31, 2022 | 776,650.25 |
| Oct 31, 2021 | 1.03 Mn |
| Jul 31, 2021 | 1.02 Mn |
| Apr 30, 2021 | 882,464.56 |